Tags

Type your tag names separated by a space and hit enter

Neutralizing Activity of BNT162b2-Elicited Serum.
N Engl J Med. 2021 04 15; 384(15):1466-1468.NEJM

Authors+Show Affiliations

University of Texas Medical Branch, Galveston, TX.University of Texas Medical Branch, Galveston, TX.University of Texas Medical Branch, Galveston, TX.University of Texas Medical Branch, Galveston, TX.University of Texas Medical Branch, Galveston, TX.Pfizer Vaccine Research and Development, Pearl River, NY.Pfizer Vaccine Research and Development, Pearl River, NY.Pfizer Vaccine Research and Development, Pearl River, NY.Pfizer Vaccine Research and Development, Pearl River, NY.Pfizer Vaccine Research and Development, Pearl River, NY.Pfizer Vaccine Research and Development, Pearl River, NY.University of Texas Medical Branch, Galveston, TX.BioNTech, Mainz, Germany.BioNTech, Mainz, Germany.Pfizer Vaccine Research and Development, Pearl River, NY.University of Texas Medical Branch, Galveston, TX xuxie@utmb.edu.Pfizer Vaccine Research and Development, Pearl River, NY philip.dormitzer@pfizer.com.University of Texas Medical Branch, Galveston, TX peshi@utmb.edu.

Pub Type(s)

Letter

Language

eng

PubMed ID

33684280

Citation

Liu, Yang, et al. "Neutralizing Activity of BNT162b2-Elicited Serum." The New England Journal of Medicine, vol. 384, no. 15, 2021, pp. 1466-1468.
Liu Y, Liu J, Xia H, et al. Neutralizing Activity of BNT162b2-Elicited Serum. N Engl J Med. 2021;384(15):1466-1468.
Liu, Y., Liu, J., Xia, H., Zhang, X., Fontes-Garfias, C. R., Swanson, K. A., Cai, H., Sarkar, R., Chen, W., Cutler, M., Cooper, D., Weaver, S. C., Muik, A., Sahin, U., Jansen, K. U., Xie, X., Dormitzer, P. R., & Shi, P. Y. (2021). Neutralizing Activity of BNT162b2-Elicited Serum. The New England Journal of Medicine, 384(15), 1466-1468. https://doi.org/10.1056/NEJMc2102017
Liu Y, et al. Neutralizing Activity of BNT162b2-Elicited Serum. N Engl J Med. 2021 04 15;384(15):1466-1468. PubMed PMID: 33684280.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Neutralizing Activity of BNT162b2-Elicited Serum. AU - Liu,Yang, AU - Liu,Jianying, AU - Xia,Hongjie, AU - Zhang,Xianwen, AU - Fontes-Garfias,Camila R, AU - Swanson,Kena A, AU - Cai,Hui, AU - Sarkar,Ritu, AU - Chen,Wei, AU - Cutler,Mark, AU - Cooper,David, AU - Weaver,Scott C, AU - Muik,Alexander, AU - Sahin,Ugur, AU - Jansen,Kathrin U, AU - Xie,Xuping, AU - Dormitzer,Philip R, AU - Shi,Pei-Yong, Y1 - 2021/03/08/ PY - 2021/3/8/entrez PY - 2021/3/9/pubmed PY - 2021/5/12/medline SP - 1466 EP - 1468 JF - The New England journal of medicine JO - N Engl J Med VL - 384 IS - 15 SN - 1533-4406 UR - https://www.unboundmedicine.com/medline/citation/33684280/Neutralizing_Activity_of_BNT162b2_Elicited_Serum_ L2 - https://www.nejm.org/doi/10.1056/NEJMc2102017?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub=pubmed DB - PRIME DP - Unbound Medicine ER -